Tobacco smoking

Tobacco smoking has been studied in 149 papers since 2016: 1 trial and 114 observational studies in people, 1 in animals, 16 reviews; 59 in the past year. The newest paper, Nov 13, 2026: “Risk factors for metabolic syndrome in first episode psychosis”.

Exposure

149 papers study it89 findingsUpdated

MeSH

Research on it is growing 26% slower than aging research as a whole: 11 papers in the latest year counted

16 new papers in 30 daysSee all 149 papers on tobacco smoking

At a glance

Independent labs found the same change in people. 46 independent labs in 23 countries.

“The mean difference of HbA1c in non-smokers and smokers was 0.43 ± 0.277 and 0.415 ± 0.230, which shows a higher mean difference in non-smokers, which was statistically non-significant.”
Evaluation of Glycosylated Hemoglobin Levels and Effect of Tobacco Smoking in Periodontally Diseased Non-Diabetic PatientsInternational journal of MCH and AIDS2024doi:10.25259/ijma_5

3 of its findings point the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 46 independent labs in 23 countries
  • 3 findings against
  • Funders: National Institutes of Health and others
  • 5 of 74 findings with company ties
  • Human trial1
  • Humans114
  • Animals1
  • In silico17

What did studies of tobacco smoking find?

27

Studies of tobacco smoking measured 27 outcomes; the most studied are telomere length (4 studies), handgrip strength (2) and walking pace (2).

Telomere length

downin silico2downin humans1no changein humans1OR 0.882

4 studies
  1. Tobacco smoking is linked with lower telomere length in humans (-0.041 (-0.054, -0.028) per 2-fold prevalence increase in smoking).

    Humansn = 337,318

  2. Tobacco smoking was not clearly linked with telomere length in humans (without lung damage).

    Humanswithout lung damageCD4+ and CD8+ T lymphocytesover 30 years

  3. Tobacco smoking decreases telomere length in silico (OR 0.882, 95% CI 0.847-0.918).

    In silico

  4. Tobacco smoking decreases telomere length in silico (MR analysis (twofold increase in prevalence of smoking)) (-0.041 [-0.054, -0.028]).

    In silicoMR analysis (twofold increase in prevalence of smoking)

More on Telomere length

Handgrip strength

no changein humans1no changein silico1

2 studies
  1. Tobacco smoking was not clearly linked with handgrip strength in humans (0.074 (-0.055, 0.204) kg).

    Humansn = 337,318

  2. Tobacco smoking showed no clear effect on handgrip strength in silico (MR analysis) (0.074 [-0.055, 0.204] kg).

    In silicoMR analysis

Walking pace

downin humans1downin silico1

2 studies
  1. Tobacco smoking is linked with worse walking pace in humans (-0.047 (-0.054, -0.033)).

    Humansn = 337,318

  2. Tobacco smoking impairs walking pace in silico (MR analysis) (-0.047 [-0.054, -0.033]).

    In silicoMR analysis

Appendicular lean mass index

downin humans1downin silico1

2 studies
  1. Tobacco smoking is linked with lower appendicular lean mass index in humans (-0.007 (-0.010, -0.005)).

    Humansn = 337,318

  2. Tobacco smoking decreases appendicular lean mass index in silico (MR analysis) (-0.007 [-0.010, -0.005]).

    In silicoMR analysis

HbA1c

no changein humans1

1 study
  1. Tobacco smoking showed no clear effect on HbA1c in humans.

    Human trial3 monthsn = 40

  2. Tobacco smoking showed no clear effect on HbA1c in humans (periodontal therapy mean difference comparison between smokers and non-smokers) (0.43 ± 0.277 vs 0.415 ± 0.230).

    Human trialperiodontal therapy mean difference comparison between smokers and non-smokersn = 40

More on HbA1c

Brain volume

downin humans1

1 study
  1. Tobacco smoking decreases brain volume in humans.

    Reviewbrain

Inflammation

upin humans1

1 study
  1. Tobacco smoking induces inflammation in humans.

    Reviewbrain

More on Inflammation

GrimAge2

upin humans1

1 study
  1. Tobacco smoking is linked with higher GrimAge2 in whole blood and isolated immune cell types.

    Humansin whole blood and isolated immune cell types

    Smoking linked to aging measures in human immune cells

    Clinical epigenetics

More on GrimAge2

DunedinPACE

upin humans1

1 study
  1. Tobacco smoking is linked with higher DunedinPACE in whole blood and isolated immune cell types.

    Humansin whole blood and isolated immune cell types

    Smoking linked to aging measures in human immune cells

    Clinical epigenetics

More on DunedinPACE

DNAmTL

downin humans1

1 study
  1. Tobacco smoking is linked with lower DNAmTL in humans across six major immune cell types.

    Humansacross six major immune cell types

    Smoking linked to aging measures in human immune cells

    Clinical epigenetics

More on DNAmTL

All 27

What is tobacco smoking linked with?

48

Studies link tobacco smoking with 48 measures, most often cancer incidence (3 studies), oxidative stress and ROS signaling (2) and multimorbidity (2).

Cancer incidence

upin humans3+15% cancer burden attributable to smoking

3 studies
  1. Tobacco smoking is associated with cancer incidence in humans (Population-attributable fraction estimates) (26.8% of cancer cases attributable to tobacco smoking).

    HumansPopulation-attributable fraction estimates

  2. Tobacco smoking is linked with a higher risk of cancer incidence in humans (Global burden in 2022) (17.2% population attributable fraction).

    HumansGlobal burden in 2022

  3. Tobacco smoking is associated with cancer incidence in humans (global estimates) (15.1% of cancer burden attributable to smoking).

    Humansglobal estimates2022

Oxidative stress and ROS signaling

upin humans2

2 studies
  1. Tobacco smoking is associated with oxidative stress and ROS signaling in humans (compared with never smokers and other tobacco use categories).

    Humanscompared with never smokers and other tobacco use categories

  2. Tobacco smoking is associated with oxidative stress and ROS signaling in humans.

    Humansn = 620

More on Oxidative stress and ROS signaling

Multimorbidity

upin humans2

2 studies
  1. Tobacco smoking is associated with multimorbidity in humans (Residents of the Manguinhos slum complex).

    HumansResidents of the Manguinhos slum complexfemales

  2. Tobacco smoking is associated with multimorbidity in humans (Women in India) (AOR 1.87, CI 1.65–2.10; population attributable risk 1.2% (p<0.001)).

    HumansWomen in Indiafemalesn = 699,686

More on Multimorbidity

Frailty

upin humans2HR 1.79

2 studies
  1. Tobacco smoking is linked with a higher risk of frailty in humans (people with HIV) (HR: 1.79; 95% confidence interval: 1.54 to 2.08).

    Humanspeople with HIVmean 5.3 yearsn = 8,608

  2. Tobacco smoking is associated with frailty in humans (P-value < 0.05).

    Humans

Fuchs endothelial corneal dystrophy

downin humans1upin humans1HR 0.92–1.12

1 study
  1. Tobacco smoking is linked with a lower risk of Fuchs endothelial corneal dystrophy in humans (former vs never smokers) (HR = 0.92, CIs: 0.84-1.01).

    Humansformer vs never smokersfemales

  2. Tobacco smoking is linked with a higher risk of Fuchs endothelial corneal dystrophy in humans (current vs never smokers) (HR = 1.12, CIs: 0.90-1.38).

    Humanscurrent vs never smokersfemales

More on Fuchs endothelial corneal dystrophy

Metabolic syndrome

upin humans1

1 study
  1. Tobacco smoking is associated with metabolic syndrome in humans (first-episode psychosis).

    Humansfirst-episode psychosis>20 cigarettes daily2 years66% malesn = 456

More on Metabolic syndrome

Parkinson's disease risk

downin humans1

1 study
  1. Tobacco smoking is associated with Parkinson's disease risk in humans (32-60% risk reduction in smokers).

    Review

More on Parkinson's disease risk

FEF25-75%

downin humans1

1 study
  1. Tobacco smoking is associated with FEF25-75% in humans (Conventional cigarette smokers compared with controls).

    HumansConventional cigarette smokers compared with controlsn = 22

More on FEF25-75%

Lung cancer mortality

upin humans1

1 study
  1. Tobacco smoking is associated with lung cancer mortality in humans (Persons with opioid use disorder).

    HumansPersons with opioid use disorderIncreasing smoking frequency

Lung cancer incidence

upin humans1

1 study
  1. Tobacco smoking is associated with lung cancer incidence in humans (Persons with opioid use disorder).

    HumansPersons with opioid use disorderIncreasing smoking frequency

All 48

What acts on tobacco smoking?

1

Studies name covid-19 pandemic as acting on tobacco smoking.

COVID-19 pandemic

upin humans1

1 study
  1. COVID-19 pandemic is linked with higher tobacco smoking in humans during the first year of the COVID-19 pandemic (2020) vs prepandemic (2011-2018) (aOR 1.12, 95% CI 1.07, 1.17).

    Humansduring the first year of the COVID-19 pandemic (2020) vs prepandemic (2011-2018)n = 44,139

Funding

1 grant since 2024

American Heart Association$152K

Latest

Dec 2025: 3Jan 2026: 6Feb 2026: 10Mar 2026: 9Apr 2026: 1May 2026: 1Jun 2026: 3Jul 2026: 5Aug 2026: 5Sep 2026: 2Oct 2026: 9Nov 2026: 559 papers in 12 months

See all 149 papers on tobacco smoking